abbvie glp 1 Obesity Late-Comer Inks up to $2.2B Amylin Deal With Gubra AbbVie finally enters obesity race

Four states dropped coverage in late 2025: California, New Hampshire, Pennsylvania , and South Carolina all eliminated Medicaid coverage of GLP-1s for obesity treatment reducing the national count from 16 states to 13

The expression of most targets of Nrf2, including the catalytic subunit ( Gclc ) and modifier subunit ( Gclm ) of the GSH synthesis rate-limiting enzyme glutamate-cysteine ligase, increased after quinpirole treatment (Fig

Research summarized by the American Psychological Association found that reducing social media use can improve how teens and young adults feel about their weight and appearance

Individual tolerance plays a major role